RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses01Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses02Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses03Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses04Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses05Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses06Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses07Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses08Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses09Member RAINBOW2022-01-012022-03-31in-bse-fin:OneOperatingExpenses10Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses01Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses02Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses03Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses04Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses05Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses06Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses07Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses08Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses09Member RAINBOW2022-01-012022-03-31in-bse-fin:FourOperatingExpenses10Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares RAINBOW 2021-04-01 2022-03-31 2022-05-20 INR Millions Yearly true Cash Flow Indirect Single segment The business of running multi-specialty pediatric and obstetrics and gynecology hospital. 2022-01-01 2022-03-31 Audited Consolidated 2124470000.00 61860000.00 2186330000.00 337610000.00 0.00 0.00 317130000.00 162780000.00 222820000.00 988400000.00 2028740000.00 157590000.00 0.00 157590000.00 55620000.00 -20630000.00 34990000.00 0.00 122600000.00 0.00 0.00 0.00 0.00 122600000.00 3170000.00 125770000.00 121940000.00 660000.00 125090000.00 680000.00 1049980000.00 10 1.36 1.33 0.00 0.00 1.36 1.33 0.00 0.04 1. The financial results of Rainbow Children's Medicare Limited (formerly known as Rainbow Children's Medicare Private Limited) ( the Company ) and its subsidiaries (the Company and its subsidiaries together referred to as the Group ) have been prepared in accordance with Indian Accounting Standards ( Ind AS ) prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with the relevant rules thereunder and in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. The above results for the quarter and year ended 31 March 2022 were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 27 May 2022. The statutory auditors have expressed an unmodified audit opinion on these results. 3. The consolidated figures for the quarter ended 31 March 2022 are the balancing figure between the audited consolidated figures in respect of the full financial year and the unpublished audited year to date consolidated figures up to the third quarter of the current financial year. 4. The consolidated figures for the quarter ended 31 March 2021 are the balancing figure between the audited figures in respect of the full financial year ended 31 March 2021 and the unpublished audited year to date figures up to the third quarter of the financial year ended 31 March 2021. 5. The consolidated figures for the quarter ended 31 December 2021 are the balancing figure between the unpublished audited year to date figures up to the third quarter of the current financial year and unpublished audited year to date figures up to the six months ended 30 September 2021 of the current financial year. 6. The Company on 1 December 2021 has issued and allotted bonus equity shares in the ratio of 1:1 for every one equity share and every one preference share held. The Company has issued and allotted equity shares through rights issue to an existing shareholder on 22 October 2021. The exercise price is less than the fair value of the equity shares and hence the inherent discount is similar to a bonus issue as per Ind AS 33. In line with the requirements of Ind AS 33, for the purpose of EPS calculations, bonus shares issued and the bonus element in rights issue of shares has been retrospectively adjusted as if the event had occurred at the beginning of the earliest period presented. 7. The Board of Directors recommend dividend for the financial year 2021-22 Rs. 2.00 (2020-21 Rs. 2.00) per Equity Share of Rs.10 each. The payment is subject to approval of the shareholders at the ensuing Annual General Meeting of the Company. 8. Subsequent to the year end, the Company has completed Initial Public Offering of 29,168,579 Equity Shares of face value of Rs. 10 each of the Company at an issue price of Rs. 542 per equity share (including a share premium of Rs. 532 per equity share, eligible employees bidding in the employee’s reservation portion were offered a discount of Rs. 20 per equity share), aggregating to Rs. 15,808.49 million comprising a fresh issue of 5,167,679 Equity Shares aggregating to Rs. 2,800.00 million and an offer for sale of 24,000,900 Equity shares aggregating to Rs. 13,008.49 million. The equity shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) with effect from 10 May 2022. Due to size constraint, please refer pdf signed results for note no.9,10 & 11. Single segment 2021-04-01 2022-03-31 Audited Consolidated 9737580000.00 189370000.00 9926950000.00 1947290000.00 0.00 0.00 1160710000.00 532030000.00 832630000.00 3580830000.00 8053490000.00 1873460000.00 0.00 1873460000.00 576130000.00 -89400000.00 486730000.00 0.00 1386730000.00 0.00 0.00 0.00 0.00 1386730000.00 10270000.00 1397000000.00 1382660000.00 4070000.00 1392890000.00 4110000.00 1049980000.00 10 0.00 14.75 14.75 0.00 0.00 14.75 14.75 0.00 0.04 Business promotion and advertisement 77400000.00 Canteen expenses 36920000.00 Communication expenses 15640000.00 Contract wages 61520000.00 Lab and investigations 29800000.00 Other Expenses 80670000.00 Power and fuel 43240000.00 Professional charges 535360000.00 Rates and taxes 29790000.00 Repairs & Maintenance 78060000.00 Business promotion and advertisement 215100000.00 Canteen expenses 145940000.00 Communication expenses 55960000.00 Contract wages 222500000.00 Lab and investigations 123050000.00 Other Expenses 319500000.00 Power and fuel 168110000.00 Professional charges 2037600000.00 Rates and taxes 103440000.00 Repairs & Maintenance 189630000.00 532030000.00 -47260000.00 8980000.00 0.00 -309600000.00 0.00 0.00 0.00 0.00 151230000.00 0.00 0.00 0.00 832630000.00 0.00 0.00 0.00 -22870000.00 0.00 -50000.00 8280000.00 0.00 0.00 -118030000.00 0.00 0.00 0.00 -28200000.00 0.00 990580000.00 2864040000.00 0.00 0.00 0.00 626760000.00 0.00 2237280000.00 0.00 0.00 88200000.00 0.00 0.00 0.00 0.00 0.00 610000.00 622250000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 197130000.00 3960000.00 0.00 0.00 11640000.00 50920000.00 0.00 -1089400000.00 0.00 -1753450000.00 10950000.00 0.00 263420000.00 0.00 0.00 0.00 0.00 0.00 0.00 60720000.00 516540000.00 0.00 92480000.00 45250000.00 0.00 0.00 -440620000.00 43210000.00 0.00 43210000.00 56580000.00 99790000.00